Ebrotidine is a new H2-receptor antagonist which exhibits a remarkable ability for gastric mucosal protection. A preliminary metabolic pathway for this compound was proposed and the hypothetic metabolites were synthesized. The presence of ebrotidine and its metabolitesebrotidine S-oxide and 4-bromobenzenesulfonamide in humanurine has been confirmed by HPLC separation and spectroscopic characterization